Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
Go back to Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 3.42 +0.32 (10.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.10 | 52 Week High | $ | |||
| Open | $3.17 | 52 Week Low | $ | |||
| Day High | $3.44 | P/E | N/A | |||
| Day Low | $3.13 | EPS | $ | |||
| Volume | 1,342,528 | |||||

